Elevance Health (ELV) Change in Acquisitions & Divestments (2010 - 2026)

Elevance Health (ELV) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $671.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments rose 1497.62% year-over-year to $671.0 million; the TTM figure through Jun 2026 stood at $2.3 billion (up 455.99% YoY), while the FY2025 annual figure was $1.8 billion, up 2526.03% from the prior year.
• Change in Acquisitions & Divestments improved to $671.0 million in Q2 2026 per ELV's latest filing, from $313.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $9.9 billion in Q4 2022 and bottomed at -$10.7 billion in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $734.7 million across 5 years, with a median of $510.5 million in 2024.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments sank 6656.52% — and 2026, when it jumped 1497.62%.
• Elevance Health's Change in Acquisitions & Divestments stood at $9.9 billion in 2022, then tumbled by 100.23% to -$23.0 million in 2023, then tumbled by 6656.52% to -$1.6 billion in 2024, then jumped by 137.07% to $576.0 million in 2025, then rose by 16.49% to $671.0 million in 2026.
• Business Quant data shows ELV's Change in Acquisitions & Divestments at $671.0 million in Q2 2026, $313.0 million in Q1 2026, and $576.0 million in Q4 2025.